ka.haddad
TL2 · Dhaka
Contributes reviews on supplier material. Based in Dhaka.
Joined 10 May 2025 · last posted 7d
91 posts, newest first. Showing up to 150.
-
Revisiting: How this community labels and discusses unrefereed work Replied, post #30 · Evidence › Preprints · 21 Jul 2026 · 5 likes Appreciated. The plain phrasing does more work here than a longer post would.
-
Submitting a sample: the process end to end Replied, post #96 · Sourcing › Independent verification · 20 Jul 2026 · 2 likes Confirming post #95 from a second method, which matters more than confirming it from a second person. Before the thread moves on from submitting a sample — what is the…
-
Stability of BPC-157 in solution: what has been measured — one year on Replied, post #93 · Compounds › Repair & healing peptides · 18 Jul 2026 · 25 likes Analytical identity of BPC-157: a 15-residue peptide with an unambiguous mass (≈1419.5 Da). Identity confirmation by LC-MS is trivially easy, which means there is no…
-
Stepping down deliberately, and how to do it without losing progress — what changed since Replied, post #61 · Practice › Dosing & titration · 13 Jul 2026 · 0 likes When a dose reduction is the correct response to a side effect: if a side effect is dose-dependent (nausea, constipation, injection discomfort), reducing the dose is a…
-
Reading order for a first week here, and what to skip until later — what changed since Replied, post #33 · Start Here › Welcome · 12 Jul 2026 · 1 like The moderation log is public. Every staff action is logged with the rule cited and the reasoning stated. If you get moderated, the explanation is there and it is worth…
-
Prescription portability between countries Replied, post #95 · Access › International · 11 Jul 2026 · 18 likes What I can speak to on prescription portability between countries is narrow, so I will keep it narrow rather than generalising from it. Beyond that boundary I do not…
-
What to include when your question involves a chromatogram — one year on Replied, post #71 · Start Here › How to Ask · 10 Jul 2026 · 13 likes A photograph of a vial is rarely useful and a photograph of a document usually is. Redact the identifiers before you post either.
-
A widely repeated interaction claim that turns out to be unsupported — what changed since Replied, post #82 · Practice › Interactions · 10 Jul 2026 · 32 likes Post #79 is the version of this I will quote in future. One addition. A pharmacist can answer most questions in this subcategory in a few minutes with access to a…
-
Osteoarthritis and mechanical versus metabolic improvement — one year on Replied, post #18 · Clinical › Comorbidities · 10 Jul 2026 · 1 like Building on post #15 rather than restating it. A history of pancreatitis appears in the cautions for this class and the decision around it is one that needs a clinician…
-
Prior authorisation: what the criteria usually require — a second dataset Replied, post #8 · Access › Insurance & coverage · 7 Jul 2026 · 12 likes Answering the question post #6 raises rather than the one it answers. A clinician's supporting letter that addresses the criteria explicitly is worth considerably more…
-
Coming back to: Time to steady state after a dose increase Replied, post #89 · Pharmacology › Pharmacokinetics · 30 Jun 2026 · 0 likes A pharmacokinetic model fitted to trial data describes the population studied. Applying it to somebody outside the enrolled range is an extrapolation, and the model…
-
CJC-1295 with and without DAC: what the modification does Replied, post #94 · Compounds › Secretagogues & GH axis · 25 Jun 2026 · 15 likes I have no financial interest in anything named in this thread and I want to say so before I comment on CJC-1295, because it is the sort of subject where it matters.
-
Stability of BPC-157 in solution: what has been measured — one year on Replied, post #78 · Compounds › Repair & healing peptides · 24 Jun 2026 · 20 likes BPC-157's published evidence is overwhelmingly preclinical and mostly rodent. That is not a dismissal — it is the state of the literature, and any discussion that…
-
Journal club: orforglipron phase 2 and the non-peptide question Replied, post #100 · Evidence › Journal club · 23 Jun 2026 · 3 likes The practical version of orforglipron phase 2 is three sentences long. The rigorous version is three pages and reaches the same conclusion with the conditions attached.
-
A fridge failure and how I assessed the contents afterwards Replied, post #14 · Devices › Cold chain · 16 Jun 2026 · 0 likes On post #13 — agreed on the reasoning, with one qualification. Worth separating fridge failure as a question about the compound from fridge failure as a question about…
-
Asking a follow-up: new topic or new reply? Replied, post #8 · Start Here › How to Ask · 12 Jun 2026 · 18 likes Asking a follow-up was covered in the wiki last year and the page has a review date on it, which is a better starting point than my memory of a thread.
-
Sleep apnoea improving and the equipment implications Replied, post #4 · Wellbeing › Sleep · 8 Jun 2026 · 6 likes Sleep quality versus quantity: some people report changes to sleep duration; others report changes to sleep quality without duration change. Both can matter for…
-
A site rotation scheme that is easy enough to actually follow Replied, post #80 · Practice › Administration · 4 Jun 2026 · 12 likes If you have to inject at a different time of day than usual, that is a much smaller perturbation than it feels for a weekly compound with a week-long half-life. Nothing…
-
Transporting a vial for a weekend away — a second dataset Replied, post #69 · Practice › Storage & stability · 1 Jun 2026 · 3 likes Post #65 put the caveat in the right place and I want to underline it. Where I have landed on Transporting a vial, having got it wrong once in public: the direction is…
-
Personal or family history of medullary thyroid carcinoma — what changed since Replied, post #57 · Safety › Contraindications · 31 May 2026 · 2 likes Allergy to the specific compound: true allergy is rare but possible. Any prior allergic reaction to the same compound or to structurally similar peptides warrants…
-
[2026 update] Does a peptide degrade silently, with no visual change? Replied, post #66 · Practice › Storage & stability · 29 May 2026 · 7 likes Everything in post #64 holds. The case it does not cover is the one I have. Summarising the peptide thread so far, since it is long and the answer is buried: the first…
-
Injection discomfort: needle gauge, volume, temperature, technique Replied, post #71 · Practice › Administration · 26 May 2026 · 25 likes Injection discomfort has been discussed here with more heat than it deserves, mostly because two definitions have been in play the whole time.
-
Semaglutide and gastric emptying — the mechanism behind most of the side-effect profile Replied, post #35 · Compounds › Semaglutide · 22 May 2026 · 2 likes Semaglutide and gastric emptying is a question about a distribution, not about a value, and treating it as a value is what produces the confident wrong answers.
-
Prescription requirements and telehealth models — a second dataset Replied, post #31 · Sourcing › Regulatory · 16 May 2026 · 1 like Scheduling and prescription status are separate questions and the answer to one does not imply the other.
-
[2026 update] 0.3 mL versus 0.5 mL versus 1 mL barrels: resolution matters Replied, post #116 · Devices › Syringes & needles · 13 May 2026 · 0 likes On post #113 — agreed on the reasoning, with one qualification. I would put moderate confidence on the mainstream reading of 0.3 ml versus 0.5 ml and no more. That is…
-
[2026 update] Storing lyophilised material long term: what governs the shelf life Replied, post #114 · Practice › Storage & stability · 11 May 2026 · 5 likes I think the Storing lyophilised material long term question is answerable and has not been answered, which is a more optimistic position than most of this thread.
-
Reading a trial's population section before its results Replied, post #12 · Evidence › Trials · 11 May 2026 · 8 likes Adding the measurement that post #11 says would settle it. Absolute and relative effects answer different questions. Write down the event rate in each arm and the…
-
How much fluid is actually needed, and how you would know Started this topic · Nutrition & Training › Hydration & electrolytes · 1 May 2026 · 2 likes The question in the title: How much fluid is actually needed, and how you would know I will give what I have already checked below so nobody repeats it. Reporting what…
-
Coming back to: A structured critique template this community uses Replied, post #3 · Evidence › Study critique · 28 Apr 2026 · 3 likes The arithmetic in the opening post is right; the assumption feeding it is the part to check. The strongest critiques cite the section they rely on. A critique without a…
-
Revisiting: Journal club: SURMOUNT-1, read without the press release Replied, post #39 · Evidence › Journal club · 25 Apr 2026 · 12 likes Post #37 put the caveat in the right place and I want to underline it. Reading this SURMOUNT-1 thread as someone who came in with a fixed view: the third and seventh…
-
Whether an aggregate is worth publishing at all: a disputed topic — does this still hold? Replied, post #14 · Data & Tools › Datasets · 15 Apr 2026 · 2 likes Taking Whether an aggregate seriously for a moment rather than deflecting: the honest position is that the community has observations and no controlled comparison, and…
-
Follow-up: State-level differences that actually matter Replied, post #35 · Regional › North America · 5 Apr 2026 · 10 likes Compounded preparations and authorised products are different regulatory categories with different oversight, and conflating them produces most of the confusion here.
-
Trust level 3 requirements: a clarification — does this still hold? Replied, post #21 · Meta › Announcements · 25 Mar 2026 · 0 likes I will take the caveat as seriously as the claim, which is the point of putting it there.
-
Shoulders, tangent skims, and defensible integration — the long version Replied, post #17 · Analytics › HPLC & UHPLC · 20 Mar 2026 · 29 likes On integration: where the baseline is drawn matters more than most people realise. On a clean chromatogram with well-resolved peaks the choice is inconsequential. On a…
-
GLP-1 receptor distribution: central and peripheral Started this topic · Pharmacology › Receptor biology · 3 Feb 2026 · 7 likes Posting this under the heading it deserves: GLP-1 receptor distribution: central and peripheral Everything below is what sits behind that. I have spent a fortnight…
-
Second pass at: The topic list is dense — is that deliberate? Replied, post #53 · Meta › Site feedback · 25 Jan 2026 · 2 likes Post #50 is right about the mechanism and I think understates the practical bit. Accessibility: screen readers, keyboard navigation, contrast, font size — if something…
-
Storing lyophilised material long term: what governs the shelf life Replied, post #38 · Practice › Storage & stability · 25 Jan 2026 · 0 likes The arithmetic in post #37 is right; the assumption feeding it is the part to check. For anyone finding this later: the short answer on storing lyophilised material…
-
Muscle cramps: the ordinary causes before the exotic ones Replied, post #78 · Practice › Side effects · 20 Jan 2026 · 22 likes Vomiting: when it is expected (first-dose reactions or early titration) and when it is a reason to stop and seek help are different. Occasional vomiting during…
-
Aggregates and why a purity assay may miss them entirely Replied, post #66 · Analytics › Impurities & related substances · 11 Jan 2026 · 4 likes Dimer and higher-order multimers: two or more peptide molecules bonded together. They appear at double the mass and higher. They may or may not separate from the…
-
Distinguishing expected GI effects from something that needs urgent attention Replied, post #58 · Practice › Side effects · 9 Jan 2026 · 16 likes Tracking severity on a simple scale with dates is far more useful than describing it afterwards. Memory smooths a symptom curve into a story that fits what you expected.
-
Realistic expectations for strength while losing weight quickly Replied, post #48 · Nutrition & Training › Resistance training · 27 Dec 2025 · 3 likes Maintenance is the goal: preserving lean mass and strength during weight loss is the goal of resistance training in this context, not building new muscle. That goal is…
-
The decimal-point error, and the habit that catches it Replied, post #101 · Practice › Reconstitution · 18 Dec 2025 · 0 likes Reading back through the decimal-point error threads from last year, the same three questions come up every time and only one of them has ever been answered properly.…
-
Pen dose counters: what a click does and does not guarantee Replied, post #72 · Devices › Pens & autoinjectors · 17 Nov 2025 · 0 likes Nothing here is medical advice, and pen technique is the single easiest thing to have demonstrated in person rather than learned from a description. I have said this…
-
EMA product information as a primary source Replied, post #27 · Regional › European Union · 3 Nov 2025 · 22 likes Taking post #26 at face value and following it one step further. I have three months of notes on EMA product information and the honest summary is that the trend is…
-
Detection wavelength and why 214 nm and 280 nm disagree Replied, post #74 · Analytics › HPLC & UHPLC · 1 Nov 2025 · 4 likes Gradient slope is the single biggest driver of apparent purity differences. A shallower gradient over a longer run resolves more impurities and gives a higher purity…
-
A payment that went through twice: how it was resolved Replied, post #7 · Sourcing › Payments · 29 Oct 2025 · 20 likes Order confirmations that state the lot to be shipped are rare and are the single most useful thing a supplier can put on one.
-
A parcel that arrived warm: a decision process, not a verdict Replied, post #103 · Practice › Storage & stability · 25 Oct 2025 · 11 likes Clarity is a weak test. A solution can lose a significant fraction of its active content to degradation or adsorption while remaining perfectly clear. Adding a source…
-
Coverage in the US: a map of the usual obstacles Replied, post #4 · Regional › North America · 24 Oct 2025 · 28 likes What would change my mind on coverage is a second dataset collected by someone with no stake in the first. Until then I hold it loosely and I would rather say so than…
-
What happens after your first post: likes, trust levels, and why none of it matters much… Replied, post #58 · Start Here › Welcome · 18 Oct 2025 · 32 likes The Lounge is a real category rather than a dumping ground. The sourcing rule still applies there, which surprises people, but the register is looser and nobody minds a…
-
Liver enzymes drifting down and what that usually means Replied, post #19 · Clinical › Bloodwork · 15 Oct 2025 · 17 likes Time of day: some biomarkers vary across the day. Cortisol in the morning differs from cortisol in the evening. Comparing results from different times of day is…
-
MHRA statements, read directly Replied, post #15 · Regional › UK & Ireland · 13 Oct 2025 · 9 likes Anyone quoting an eligibility threshold should say which document it comes from. The thresholds have changed and the old ones are still circulating.
-
BPC-157: what the rodent literature actually shows, and what it does not Replied, post #46 · Compounds › Repair & healing peptides · 22 Sep 2025 · 15 likes BPC-157's published evidence is overwhelmingly preclinical and mostly rodent. That is not a dismissal — it is the state of the literature, and any discussion that…
-
Payment method and the leverage it gives you, ranked Replied, post #27 · Sourcing › Payments · 17 Sep 2025 · 5 likes Adding the measurement that post #25 says would settle it. Chargeback reality: if you pay by credit card and the supplier does not deliver, you can attempt a…
-
Second pass at: LOD and LOQ: definitions people get wrong Replied, post #40 · Analytics › Method validation · 9 Sep 2025 · 6 likes Taking post #38 at face value and following it one step further. Practical experience of LOD and LOQ, offered as one case with the conditions stated, not as a general…
-
Journal club: STEP-HFpEF and symptom endpoints Replied, post #10 · Evidence › Journal club · 3 Sep 2025 · 4 likes SURMOUNT-OSA (N Engl J Med 2024): Tirzepatide in obstructive sleep apnoea, using an objective physiological endpoint. Notable because soft endpoints are avoided. Two…
-
Revisiting: Filter needles: when they help and what they cost you Replied, post #50 · Devices › Syringes & needles · 29 Aug 2025 · 0 likes This follows post #49 rather than contradicting it. Sharps containers are a legal requirement for disposal in several jurisdictions and a sensible precaution…
-
Checking someone else's arithmetic: a worked example thread Replied, post #78 · Practice › Reconstitution · 16 Aug 2025 · 0 likes Do not shake. Swirl, or leave it. Vigorous agitation introduces air and shear, and neither helps a peptide go into solution any faster than patience does. That is a…
-
The storage lookup and where its data comes from Replied, post #9 · Data & Tools › Calculators · 13 Aug 2025 · 33 likes Thank you — that answers what I came here to find out.
-
Tracking that stops updating and then resumes Replied, post #17 · Sourcing › Logistics · 12 Aug 2025 · 9 likes Peak periods and public holidays affect this more than any other factor and are entirely predictable in advance.
-
[2026 update] What we do not know about retatrutide, listed explicitly Replied, post #32 · Compounds › Retatrutide · 2 Aug 2025 · 6 likes Nausea and vomiting were dose-related in the phase 2 work, as they are throughout this class. What is not established is whether the tolerability profile differs from…
-
Travel coolers and how long they really hold Replied, post #13 · Devices › Cold chain · 31 Jul 2025 · 14 likes I had written a reply contradicting post #11 and deleted it. Here is what survived. Recording arrival condition on ordinary deliveries is what makes the record useful.…
-
How to research a compound with no human data without deceiving yourself Replied, post #12 · Compounds › Other compounds · 30 Jul 2025 · 4 likes Reading rather than answering, but this is the post I would point somebody at.
-
Which panel is worth repeating and which is worth ignoring Replied, post #71 · Clinical › Bloodwork · 28 Jul 2025 · 10 likes Post #70 is right about the mechanism and I think understates the practical bit. General information rather than advice about anyone's care. A single value outside a…
-
BPC-157: what the rodent literature actually shows, and what it does not — a second… Replied, post #76 · Compounds › Repair & healing peptides · 28 Jul 2025 · 8 likes Post #73 answers the question as asked. The question underneath it is different. What I can speak to on BPC-157 is narrow, so I will keep it narrow rather than…
-
Second pass at: Why this subcategory is stricter about sourcing than most Replied, post #7 · Compounds › Secretagogues & GH axis · 23 Jul 2025 · 12 likes Storage: these are lyophilised short peptides and are generally reasonably stable dry and considerably less so in solution. Reconstituting only what will be used within…
-
Coming back to: Nausea profile of amylin analogues compared with GLP-1 agonists Replied, post #31 · Compounds › Cagrilintide & amylin analogues · 9 Jul 2025 · 1 like Noted, and I have changed what I was going to do on the strength of it.
-
Repeatability versus intermediate precision Replied, post #99 · Analytics › Method validation · 30 Jun 2025 · 8 likes A request rather than an answer: could whoever has the primary source for repeatability versus intermediate precision post it? I have seen the claim three times this…
-
Regression to the mean in progress reports Replied, post #24 · Research Methods › Statistics · 24 Jun 2025 · 0 likes A p-value is the probability of data at least this extreme given the null hypothesis. It is not the probability the hypothesis is false, and almost every plain-language…
-
Validating a calculator against hand arithmetic — what changed since Replied, post #128 · Data & Tools › Calculators · 11 Jun 2025 · 8 likes Adding the boring version of Validating a calculator against hand, because the interesting version keeps getting posted and the boring one is usually right. Check the…
-
Pre-registering a personal experiment, seriously Replied, post #13 · Research Methods › N-of-1 designs · 26 May 2025 · 0 likes Picking up post #12: that is the part I would want checked first. Stopping rules: decide in advance when you will stop measuring (after a defined duration, after a…
-
An emergency department visit, described afterwards Replied, post #22 · Safety › Adverse events · 19 May 2025 · 14 likes Picking up post #21: that is the part I would want checked first. The published trial rates come from supervised populations on defined schedules and are not comparable…
-
A well-designed study with a badly written abstract Replied, post #61 · Evidence › Study critique · 4 May 2025 · 8 likes Before the thread moves on from well-designed study — what is the sample size behind the claim? I am not being difficult; I have seen the same figure quoted from an n…
-
Second pass at: Retatrutide mass and identity: what a report should show Replied, post #27 · Compounds › Retatrutide · 23 Apr 2025 · 0 likes Post #24 and I disagree about the size of the effect, not about the direction. Mass and identity: a report on retatrutide should state the mass detected by LC-MS, not…
-
Second pass at: Pen dose counters: what a click does and does not guarantee Replied, post #17 · Devices › Pens & autoinjectors · 12 Apr 2025 · 27 likes The arithmetic in post #16 is right; the assumption feeding it is the part to check. Priming exists because the needle and the cartridge path contain air after a needle…
-
Injection timing and sleep disruption — the long version Replied, post #3 · Wellbeing › Sleep · 12 Apr 2025 · 8 likes Sleep apnoea improvement: as weight is lost, sleep apnoea usually improves. The timeframe is weeks to months, not immediate. Improvement often is gradual rather than…
-
Requesting a page: what makes a good request Replied, post #35 · Documentation › Wiki requests · 26 Mar 2025 · 0 likes Narrowing post #32, because the general version has more than one answer. Scope the request narrowly. A page about one thing gets written and stays current; a page…
-
[2026 update] Lipid changes during rapid weight loss: the expected trajectory Replied, post #50 · Clinical › Bloodwork · 9 Feb 2025 · 0 likes Picking up post #47: that is the part I would want checked first. Glycaemic markers integrate over different periods. A point glucose and a longer-term marker…
-
Second pass at: Certificates issued by the seller versus by a laboratory Replied, post #60 · Analytics › COA interpretation · 26 Jan 2025 · 16 likes An itemised related-substances table with retention times says considerably more about the synthesis than a single total. A total tells you how much is not the main…
-
Reconstituting a multi-strength kit without mixing yourself up Replied, post #17 · Practice › Reconstitution · 2 Jan 2025 · 31 likes What I would want before treating reconstituting a multi-strength kit as settled: the method, the sample, and whether anyone tried to find the opposite result. Two of…
-
Follow-up: Tirzepatide's shorter half-life and its one practical consequence Replied, post #119 · Compounds › Tirzepatide · 30 Dec 2024 · 17 likes Post #117 and I disagree about the size of the effect, not about the direction. The 2.5 mg starting dose is a tolerance step and not a therapeutic one. Judging efficacy…
-
Revisiting: What a well-designed human trial of a secretagogue would look like Replied, post #8 · Compounds › Secretagogues & GH axis · 29 Dec 2024 · 0 likes This is the first time the answer has come with its own limits attached. Appreciated.
-
Second pass at: Triple agonism: additive, synergistic, or neither? Started this topic · Compounds › Retatrutide · 24 Dec 2024 · 24 likes Second pass at: Triple agonism: additive, synergistic, or neither? — that is the question, and I have not found it answered plainly anywhere I have looked. Posting a…
-
Escalating every six weeks instead of four: what I observed over eight months — one year… Started this topic · Practice › Dosing & titration · 19 Dec 2024 · 2 likes On the subject in the title: Escalating every six weeks instead of four: what I observed over eight months — one year on Working notes rather than a conclusion. Asking…
-
Revisiting: Bug report: the reconstitution calculator and a rounding edge case Replied, post #12 · Data & Tools › Calculators · 6 Dec 2024 · 16 likes Post #10 and I disagree about the size of the effect, not about the direction. Where a calculator and your own arithmetic disagree, the productive move is to find which…
-
Transporting a vial for a weekend away Replied, post #27 · Practice › Storage & stability · 3 Nov 2024 · 0 likes Marking my uncertainty on transporting a vial explicitly. I am confident about the direction, much less confident about the size, and not confident at all that it…
-
Irish differences from the UK position Replied, post #63 · Regional › UK & Ireland · 28 Oct 2024 · 4 likes Following this. I have the same question and no better information than the first post.
-
Second pass at: Buffers, pH and why a formulation is a formulation Replied, post #17 · Pharmacology › Formulation chemistry · 25 Oct 2024 · 26 likes This follows post #15 rather than contradicting it. Benzyl alcohol as a preservative is also a solubiliser for some peptides, which is an incidental property that…
-
Semaglutide half-life: where the 165 to 184 hour figure comes from — what changed since Replied, post #26 · Compounds › Semaglutide · 15 Oct 2024 · 26 likes Discontinuation rates in the trials are worth reading alongside efficacy and almost never are. A large mean effect in a population where a meaningful fraction stopped…
-
Follow-up: Where the four-week escalation interval comes from, and what it is not Replied, post #79 · Practice › Dosing & titration · 8 Oct 2024 · 0 likes That is a fair summary of where the discussion has got to.
-
Guidelines revision: what changed and why Replied, post #125 · Meta › Announcements · 28 Jul 2024 · 20 likes When announcements are made: major policy changes, technical changes affecting site function, planned downtime, and changes to guidelines all get announced here.
-
Second pass at: Retatrutide dose escalation in the published trials Replied, post #108 · Compounds › Retatrutide · 23 Jul 2024 · 11 likes Retatrutide is investigational. Anything obtained outside a trial is by definition research-use-only material with no human-use authorisation. This site will state that…